<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9000850</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2507</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Opin. Pediatr.</journal-id>
<journal-title-group>
<journal-title>Current opinion in pediatrics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1040-8703</issn>
<issn pub-type="epub">1531-698X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31693580</article-id>
<article-id pub-id-type="pmc">7197344</article-id>
<article-id pub-id-type="doi">10.1097/MOP.0000000000000815</article-id>
<article-id pub-id-type="manuscript">NIHMS1549375</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical Utility of Genomic Sequencing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Neu</surname>
<given-names>Matthew B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bowling</surname>
<given-names>Kevin M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cooper</surname>
<given-names>Gregory M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA</aff>
<aff id="A2"><label>2</label>Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A3"><label>3</label>University of Alabama at Birmingham Medical Scientist Training Program, Birmingham, AL, USA</aff>
<author-notes>
<corresp id="CR1">Corresponding Author: Gregory M. Cooper, HudsonAlpha Institute for Biotechnology, 601 Genome Way, Huntsville, AL 35806, Phone: 256-327-9490, Fax: 256-327-0978, <email>gcooper@hudsonalpha.org</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P28">Conflicts of Interest</p>
<p id="P29">The authors declare no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>04</day>
<month>5</month>
<year>2020</year>
</pub-date>
<volume>31</volume>
<issue>6</issue>
<fpage>732</fpage>
<lpage>738</lpage>
<!--elocation-id from pubmed: 10.1097/MOP.0000000000000815-->
<abstract id="ABS1">
<sec id="S1">
<title>Purpose of Review</title>
<p id="P1">Identifying pathogenic variation underlying pediatric developmental disease is critical for medical management, therapeutic development, and family planning. This review summarizes current genetic testing options along with their potential benefits and limitations. We also describe results from large-scale genomic sequencing projects in pediatric and neonatal populations with a focus on clinical utility.</p>
</sec>
<sec id="S2">
<title>Recent Findings</title>
<p id="P2">Recent advances in DNA sequencing technology have made genomic sequencing a feasible and effective testing option in a variety of clinical settings. These cutting-edge tests offer much promise to both medical providers and patients as it has been demonstrated to detect causal genetic variation in ~25% or more of previously unresolved cases. Efforts aimed at promoting data sharing across clinical genetics laboratories and systematic reanalysis of existing genomic sequencing data have further improved diagnostic rates and reduced the number of unsolved cases.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">Genomic sequencing is a powerful and increasingly cost-effective alternative to current genetic tests and will continue to grow in clinical utility as more of the genome is understood and as analytical methods are improved. The evolution of genomic sequencing is changing the landscape of clinical testing and requires medical professionals who are adept at understanding and returning genomic results to patients.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Genome sequencing</kwd>
<kwd>genetic testing</kwd>
<kwd>pediatrics</kwd>
<kwd>genetic diagnostics</kwd>
<kwd>rare disease</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>